In briefBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7498.982 (Published 28 April 2005) Cite this as: BMJ 2005;330:982
Epilepsy drug trials to be reviewed: The US Food and Drugs Administration is calling on all manufacturers of epilepsy drugs to review their trial databases to see whether any possible link with suicide is shown. The call comes after claims by the New York personal injury lawyers Finkelstein and Partners that gabapentin (Neurontin), a Pfizer product that …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial